Ovid Therapeutics Inc. Deferred Costs, Current
Ovid Therapeutics Inc. (OVID) had Deferred Costs, Current of $1.93 million as of 2017-03-31, per its 10-Q filed 2017-06-13.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCostsCurrent · last filed 2018-03-29
- 2017-03-31: Deferred Costs, Current $1.93M.
- 2016-12-31: Deferred Costs, Current $242.67K.
| Period end | Deferred Costs, Current |
|---|---|
| 2017-03-31 | $1.93M 10-Q · filed 2017-06-13 |
| 2016-12-31 | $242.67K 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |